Table 2.

Characteristics patients experiencing treatment failure after CRT

No.	Tumor location	Response	Time to failure	Survival	Recurrent location	Treatment after failure
1	Lt	CR	41	Deceased	LN	Chemotherapy
2	Mt	CR	30	Deceased	LN	Surgery
3	Lt	CR	30	Survive	Local	ESD
4	Mt	CR	28	Deceased	LN	Chemotherapy
5	Lt	CR	20	Survive	LN	Surgery
6	Mt	CR	20	Survive	LN	Surgery
7	Mt	CR	10	Deceased	LN	Chemotherapy
8	Mt	CR	8	Survive	Local	ESD
9	Ut	CR	8	Deceased	LN	Surgery
10	Mt	No CR	8	Deceased	Liver	Chemotherapy
11	Mt	No CR	5	Survive	LN	Surgery
12	Mt	No CR	4	Survive	Local	Surgery
13	Mt	No CR	4	Survive	Local	Surgery
14	Mt	No CR	4	Deceased	LN	Surgery
15	Mt	No CR	3	Unknown	Lung	Chemotherapy

UT, upper thoracic; MT, middle thoracic; LT, lower thoracic; LN, lymph node; ESD, endoscopic submucosal dissection.